β-Adrenoceptor mediated signal transduction in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters

  • Deepak Kaura
  • Nobuakira Takeda
  • Rajat Sethi
  • Xi Wang
  • Makoto Nagano
  • Naranjan S. Dhalla
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 17)


In view of the lack of information regarding the status of β-adrenoceptor mediated signal transduction mechanisms at severe stages of congestive heart failure, the status of β-adrenoceptors, G-proteins and adenylyl cyclase activities was examined in 220–275 day old cardiomyopathic hamster hearts. Although no changes in the Kd values for β1- and β2-adrenoceptors were seen, the number of β1-adrenoceptors, unlike that of β2-adrenoceptors, was markedly decreased in cardiac membranes from failing hearts. The activation of adenylyl cyclase in the failing hearts by different concentrations of isoproterenol was also attenuated in comparison to the control preparations. The basal adenylyl cyclase activity in cardiac membranes from the failing hearts was not altered; however, the stimulated enzyme activities, when measured in the presence of forskolin, NaF or Gpp(NH)p were depressed significantly. The functional activity of Gs-proteins (measured by cholera toxin stimulation of adenylyl cyclase) was depressed whereas that of Gi-proteins (measured by pertussis toxin stimulation of adenylyl cyclase) was increased in the failing hearts. Not only were the Gs- and Gi-protein contents (measured by immunoblotting) increased, the bioactivities of these proteins as determined by ADP-ribosylations in the presence of cholera toxin and pertussis toxin, respectively, were also higher in failing hearts in comparison to the control values. Northern blot analysis revealed that the signals for Gs- and Gi-protein mRNAs were augmented at this stage of heart failure. These results indicate that the loss of adrenergic support at severe stages of congestive heart failure in cardiomyopathic hamsters may involve a reduction in the number of β1-adrenoceptors, and an increase in Gi-protein contents as well as bioactivities in addition to an uncoupling of Gs-proteins from the catalytic site of adenylyl cyclase in cardiac membrane.

Key words

cardiac β-adrenoceptors adenylyl cyclase in heart myocardial G-proteins signal transduction mechanisms congestive heart failure cardiomyopathic hamsters 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parmley WW: Pathophysiology of congestive heart failure. Am J Cardiol 55: 9A–14A, 1985PubMedCrossRefGoogle Scholar
  2. 2.
    Dhalla NS, Das PK, Sharma GP: Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol 10: 363–385, 1978PubMedCrossRefGoogle Scholar
  3. 3.
    Dhalla NS, Elimban V, Rupp H, Takeda N, Nagano M: Role of calcium in cardiac cell damage and dysfunction. In: N. Sperelakis (ed.). Physiology and Pathophysiology of the Heart. 3rd ed. Kluwer Academic Publishers, Boston, 1995, pp 605–623Google Scholar
  4. 4.
    Dzau VJ, Colucci WS, Hollenberg NK, William GH: Relation of the renin angiotensin aldosterone system to clinical state in congestive heart failure. Circulation 63: 645–651, 1981PubMedCrossRefGoogle Scholar
  5. 5.
    Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823, 1984PubMedCrossRefGoogle Scholar
  6. 6.
    Stiles GL, Caron MG, Lefkowitz RJ: Beta adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64: 661–743, 1984PubMedGoogle Scholar
  7. 7.
    Homey CJ, Vatner SF, Vatner SE: Beta adrenergic receptor regulation in the heart in pathophysiologic state: abnormal adrenergic responsiveness in cardiac disease. Ann Rev Physiol 53: 137–159, 1991CrossRefGoogle Scholar
  8. 8.
    Bristow M, Ginsburg R, Minobe W, Cobicciotti R, Sageman S, Lauri K, Billingham M, Harrison D, Stinson E: Decreased catecholamine sensitivity and β-adrenergic-reeeptor density in failing hearts. N Engl J Med 307: 205–211, 1982PubMedCrossRefGoogle Scholar
  9. 9.
    Bristow MR, Feldman AM: Changes in the receptor-G protein adenylyl cyclase system in heart failure from various types of heart muscle disease. Basic Res Cardiol 87 (Suppl 1): 15–35, 1992PubMedGoogle Scholar
  10. 10.
    Bohm M, Gierschik P, Erdmann E: Quantification of Gi-proteins in the failing and nonfailing human myocardium. Basic Res Cardiol 87 (Suppl 1): 37–50, 1992PubMedGoogle Scholar
  11. 11.
    Sethi R, Takeda N, Nagano M, Dhalla NS: β-adrenergic receptor mechanisms in heart failure. In: RK. Singal, I.M.C. Dixon, R.E. Beamish, N.S. Dhalla (eds). Mechanisms of Heart Failure. Kluwer Academic Publishers, Boston, 1995, pp 19–35CrossRefGoogle Scholar
  12. 12.
    Sulakhe PV, Dhalla NS: Adenylyl cyclase activity in failing hearts of genetically myopathic hamsters. Biochem Med 6: 471–482, 1972PubMedCrossRefGoogle Scholar
  13. 13.
    Harrow JAC, Singh JN, Jasmin G, Dhalla NS: Studies on adenylate cyclase-cyclic AMP system of the myopathic hamster (UM-X7.1) skeletal and cardiac muscles. Can J Biochem 53: 1122–1127, 1975PubMedCrossRefGoogle Scholar
  14. 14.
    Dhalla NS, Singh JN, Bajusz E, Jasmin G: Comparison of heart sarco-lemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters. Clin Sci Mol Med 51: 233–242, 1976PubMedGoogle Scholar
  15. 15.
    Karliner JS, Alabaster C, Stephens H, Barnes P, Dollery C: Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc Res 15: 296–304, 1971CrossRefGoogle Scholar
  16. 16.
    Kessler PD, Cates AE, Van Dop C, Feldman AM: Decreased bioactivities of the guanine nucleotide-binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters. J Clin Invest 84: 244–252, 1989PubMedCrossRefGoogle Scholar
  17. 17.
    Katoh Y, Komuro I, Takaku F, Yamaguchi H, Yazaki Y: Messenger RNA levels of guanine nucleotide-binding proteins are reduced in the ventricle of cardiomyopathic hamsters. Circ Res 67: 235–239, 1990PubMedGoogle Scholar
  18. 18.
    Sen L, Liang BT, Colucci WS, Smith TW: Enhanced α1-adrenergic activity in cardiomyopathic hamster cardiac myocytes. Relation to expression of pertussis toxin-sensitive G-proteins and α1-adrenergic receptors. Circ Res 67: 1182–1192, 1990PubMedGoogle Scholar
  19. 19.
    Horackova M, Beresewicz A, Rowden G, Wilkinson M: Neurohumoral regulation of excitation-contraction coupling in ventricular myocytes from cardiomyopathic hamsters. Cardiovasc Res 25: 1023–1034, 1991PubMedCrossRefGoogle Scholar
  20. 20.
    Chidiac P, Nagy A, Sole MJ, Wells JW: Inefficient muscarinic transduction in cardiomyopathic Syrian hamsters. J Mol Cell Cardiol 23: 1255–1269, 1991PubMedCrossRefGoogle Scholar
  21. 21.
    Ikegaya T, Kobayashi A, Hong RB, Masuda H, Kaneko M, Noboru Y: Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in BIO 14.6 cardiomyopathic hamsters at the hypertrophic stage. Mol Cell Biochem 110: 83–90, 1992PubMedCrossRefGoogle Scholar
  22. 22.
    Urasawa K, Sato K, Igarashi Y, Kawaguchi H, Yasuda H: A mechanism of catecholamine tolerance in congestive heart failure — alterations in hormone sensitive adenylyl cyclase system of the heart. Jap Circ J 56: 456–461, 1992PubMedCrossRefGoogle Scholar
  23. 23.
    Tawarahara K, Kurata C, Taguchi T, Kobayashi A, Yamazaki N: Augmentation of β adrenergic receptors in cardiomyopathic hamsters (BIO 14.6) with heart failure. Cardiovasc Res 26: 526–533, 1992PubMedCrossRefGoogle Scholar
  24. 24.
    Sethi R, Panagia V, Dhalla KS, Beamish RE, Jasmin G, Dhalla NS: Status of β-adrenergic mechanisms during the development of congestive heart failure in cardiomyopathic hamsters (UM-X7.1). In: M. Nagano, N. Takeda, N.S. Dhalla (eds). The Cardiomyopathic Heart. Raven Press, New York, 1994, pp 73–86Google Scholar
  25. 25.
    Dhalla NS, Lee SL, Shah KR, Elimban V, Suzuki S, Jasmin G: Behavior of subcellular organelles during the development of congestive heart failure in cardiomyopathic hamsters (UM-X7.1). In: M. Nagano, N. Takeda, N.S. Dhalla (eds). The Cardiomyopathic Heart. Raven Press, New York, 1994, pp 1–14Google Scholar
  26. 26.
    Sethi R, Bector N, Takeda N, Nagano M, Jasmin G, Dhalla NS: Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters. Mol Cell Biochem 140: 163–170, 1994PubMedCrossRefGoogle Scholar
  27. 27.
    Brodde DE, Zerkowski HR, Doetsch N, Motomura S, Khamssi M, Michel MC: Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta1- and beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 14: 323–331, 1989PubMedCrossRefGoogle Scholar
  28. 28.
    Wagner JA, Reynold IJ, Weisman HF, Dudeck ML, Weisfeldt ML, Snyder SH: Alterations in calcium antagonist receptors and sodium calcium exchange in cardiomyopathic hamster tissue. Circ Res 65: 205–214, 1989PubMedGoogle Scholar
  29. 29.
    Sethi R, Dhalla KS, Shah KR, Dhalla NS: Characterization of adenylyl cyclase in heart sarcolemma in the absence or presence of alamethicin. Mol Cell Biochem 119: 185–193, 1993PubMedCrossRefGoogle Scholar
  30. 30.
    Salmon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541–548, 1974CrossRefGoogle Scholar
  31. 31.
    Dixon IMC, Dhalla NS: Alterations in cardiac adrenoceptors in congestive heart failure secondary to myocardial infarction. Coronary Artery Disease 2: 805–814, 1991Google Scholar
  32. 32.
    Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ: Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87: 454–463, 1993PubMedGoogle Scholar
  33. 33.
    Jones DT, Reed RR: Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem 262: 14241–14249, 1987PubMedGoogle Scholar
  34. 34.
    Sethi R, Dhalla KS, Panagia V, Dhalla NS: Status of post adrenergic receptor mechanisms in cardiac hypertrophy and heart failure. In: N.S. Dhalla, G.N. Pierce, V. Panagia, R.E. Beamish (eds). Heart Hypertrophy and Failure. Kluwer Academic Publishers, Boston, 1995, pp 419–446CrossRefGoogle Scholar
  35. 35.
    Kagiya T, Hori M, Iwakura K, Iwai K, Watanabe Y, Uchida S, Yoshida H, Katabatake A, Inoue M, Kamada T: Role of increased α1-adrenergic activity in cardiomyopathic Syrian hamster. Am J Physiol 260: H80–H88, 1991PubMedGoogle Scholar
  36. 36.
    Bristow MR, Minobe WA, Reynold MV, Post JD, Rasmussen R, Roy PE, Feldman AM: Reduced β1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92: 2737–2745, 1993PubMedCrossRefGoogle Scholar
  37. 37.
    Bohm M, Gierschik P, Jakobs K, Pieske B, Schnabel P, Ungerer M, Erdmann E: Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82: 1249–1265, 1990PubMedCrossRefGoogle Scholar
  38. 38.
    Sole MJ, Lo CM, Laird CW, Sonnenblick EH, Wurtzman RJ: Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ Res 37: 855–862, 1975PubMedGoogle Scholar
  39. 39.
    Reithmann C, Gierschik P, Sidiropoulos D, Werdan K, Jakobs KH: Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunits. Eur J Pharmacol 172: 211–221, 1989PubMedCrossRefGoogle Scholar
  40. 40.
    Horn EM, Bilezekian JP: Mechanisms of abnormal transmembrane signalling of the β-adrenergic receptor in congestive heart failure. Circulation 82 (Suppl I): 26–34, 1990Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Deepak Kaura
    • 1
    • 2
  • Nobuakira Takeda
    • 3
  • Rajat Sethi
    • 1
    • 2
  • Xi Wang
    • 1
    • 2
  • Makoto Nagano
    • 3
  • Naranjan S. Dhalla
    • 1
    • 2
  1. 1.Division of Cardiovascular SciencesSt. Boniface General Hospital Research CentreWinnipegCanada
  2. 2.Department of Physiology, Faculty of MedicineUniversity of ManitobaWinnipegCanada
  3. 3.Department of Internal Medicine, Aoto HospitalJikei UniversityTokyoJapan

Personalised recommendations